All stock lists
Exagen Inc. (NASDAQ:XGN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
7.43
Insider Score
––Not scored
XGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
XGN analyst forecast
XGN analyst consensus
Moderate Buy4 ratings
Buy 4 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
XGN 12-month price target
$11.00+48.3% upsideaverage of 1 firm
$11.00High
$11.00Low
Best analysts covering XGN
- Canaccord Genuity25%success rate · 4 calls
- Keybanc0%success rate · 5 calls
- BTIG0%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
XGN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Canaccord Genuity | Buy | $11.00 | +42.5% | Reiterated | 2026-10-19 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-13 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-05 |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-05 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2026-08-05 |
| — | BTIG | Buy | — | — | Reiterated | 2026-05-12 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-20 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-03-11 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-03-11 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2026-03-11 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-10 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-02-24 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-17 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2026-01-30 |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-10 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2025-11-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-10-27 |
| — | BTIG | Buy | — | — | Reiterated | 2025-10-22 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-10-14 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-07-30 |
| — | Keybanc | Overweight | — | — | Upgraded | 2025-07-30 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-05-15 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-05-13 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-01-13 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-01-03 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-05-14 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-09-26 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-08-22 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-05-16 |
| — | BTIG | Buy | — | — | Reiterated | 2023-03-22 |
| — | BTIG | Buy | — | — | Reiterated | 2022-11-17 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2022-11-15 |
| — | Keybanc | Overweight | — | — | Reiterated | 2022-05-13 |
| — | Keybanc | Overweight | — | — | Reiterated | 2022-03-25 |
| — | Keybanc | Overweight | — | — | Reiterated | 2021-11-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2021-04-15 |
| — | Keybanc | Overweight | — | — | Reiterated | 2021-03-02 |
| — | KeyBanc | Overweight | — | — | Reiterated | 2021-03-02 |
| — | KeyBanc | Overweight | — | — | Reiterated | 2021-03-01 |
| — | KeyBanc | Overweight | — | — | Reiterated | 2020-11-10 |
| — | BTIG | Buy | — | — | Reiterated | 2020-10-08 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2019-11-13 |
| — | William Blair | Outperform | — | — | Reiterated | 2019-10-14 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2019-10-14 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2019-10-14 |
XGN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-10 | -0.20 | -0.20 | $16.6M | $16.6M |
| 2026-05-11 | -0.24 | -0.17 | $16.4M | $17.3M |
| 2026-08-04 | -0.19 | -0.13 | $17.8M | $19.9M |
| 2026-11-03 | -0.19 | 0.00 | $18.3M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.